Celgene MPACT Study Data Presentation
Green screen film production
Film transcript
It's my privilege to present data from the EMPAK study following the recent approval of Alvarexane in metastatic pancreatic cancer and being an investigator in a EMPAK study that led to this approval. At 151 sites in 11 countries between May 2009 and April 2012, four hundred and thirty one patients were assigned to receive nabapaclitazol pugencitabine and four thirty to receive gemcitabine alone. And so, they awaited the study results. There was a significant improvement in survival with abrexane germ that persists at all time points. In summary, adverse events were acceptable and manageable, and serious life threatening toxicity was not increased, Though there was an increase in the rates of myelosuppression and reversible peripheral neuropathy. And findings from EMPACT indicate that Abraxane is a novel agent for patients with metastatic pancreatic cancer. This large phase three trial demonstrates that its addition to gemcitabine significantly improved overall survival by 1.8 months, as well as progression free survival and response rate, meaning a positive impact of Abraxane on clinical practice to help fulfill the unmet need.
Transcript generated automatically.
Three animated films for Celgene’s MPACT symposium, turning complex pancreatic cancer research into clear presentations led by international experts.
The brief
Celgene needed a series of films for its symposium at the Beaujon Conference in Paris, presenting research into metastatic pancreatic cancer and the findings of the MPACT study.
The films would feature three international experts, each addressing a different aspect of the disease: the history of treatment, new approaches and clinical trial results, and the epidemiology and complexity of pancreatic tumours.
The challenge was to communicate detailed scientific information in an engaging format, making complex data and research accessible to a specialist audience.
The idea
Rather than relying on conventional filmed presentations, we created a green-screen format that placed each expert inside an animated visual environment.
Presenters could interact directly with on-screen graphics, data, charts and diagrams, helping explain the research as they spoke. The format combined expert commentary with bespoke animation to make the information easier to follow.
The production
Blonde produced three films, each approximately five to nine minutes long, featuring Professor Juan Valle, Professor Michele Reni and Professor Michel Ducreux.
Filming took place across three locations: Manchester, Milan and Paris. Each presenter was filmed against a green screen, using autocue and carefully planned movements to interact with the graphics.
In post-production, we edited the presentations, keyed the green-screen footage and created bespoke animation to illustrate the clinical data, research findings and supporting references.
All three films were delivered in time for the symposium at the Beaujon Conference.
The results
Three finished films were delivered ahead of the Celgene symposium, each pairing a leading expert with bespoke animated data.
Each film combined specialist commentary with animated data visualisation, creating a consistent format across the three presentations.
Blonde’s role
Visual planning, international filming, production, green-screen editing, animation and post-production.
Credits
Client: Celgene
Agency: Virgo Health
Presenters: Professor Juan Valle, Professor Michele Reni and Professor Michel Ducreux
Production: Blonde
